Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030610 · ClinicalTrials.gov registry record · NA
Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05030610 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 13 participants.
The verdict
NCT05030610, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The present study aims to adapt and evaluate the feasibility of the BeatIt behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with autistic individuals, with and without intellectual disabilities.
Interventions
- BEHAVIORAL BeatIt-ASD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-08-25 |
| Est. Completion | 2022-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05030610
The ClinicalTrials.gov registry entry for NCT05030610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BeatIt-ASD is the first listed.
NCT05030610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05030610 about?
NCT05030610 is a clinical study titled "Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults". The present study aims to adapt and evaluate the feasibility of the BeatIt behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with autistic individuals, with and without intellectual disabilities.
What is the current status of trial NCT05030610?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-08-25. Estimated completion is 2022-12-07.
What interventions are being tested in trial NCT05030610?
The interventions under investigation include: BeatIt-ASD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05030610?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.